Screening outcomes from patients with suspected multidrug-resistant tuberculosis: Lessons learned in the Philippines

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 10, 2012, Pages 1326-1330

  Gler, M T ^a   Guilatco, R S ^a   Guray, C V ^a   Tupasi, T E ^a  

^a Tropical Disease Foundation   (Philippines)

Author keywords

High burden countries; MDR TB; Treatment

Indexed keywords

ETHAMBUTOL; ISONIAZID; KANAMYCIN; LEVOFLOXACIN; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; DELAYED DIAGNOSIS; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIDRUG RESISTANT TUBERCULOSIS; NONHUMAN; OUTCOME ASSESSMENT; PHILIPPINES; PRIORITY JOURNAL; SCREENING; SHORT COURSE THERAPY; SPUTUM CULTURE; SPUTUM SMEAR; TREATMENT REFUSAL;

ADULT; ANTITUBERCULAR AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PHILIPPINES; PREVALENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

EID: 84866450312     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.12.0038     Document Type: Article

References (10)

1. Philippines Nationwide Tuberculosis Drug Resistance Survey Team. Nationwide drug resistance survey of tuberculosis in the Philippines. Int J Tuberc Lung Dis 2009; 13: 500-507.
2. World Health Organization. Treatment of tuberculosis: guidelines. 4th ed. WHO/HTM/TB/2009.420. Geneva, Switzerland: WHO, 2009.
3. Gler M T, Macalintal L E, Raymond L, Guilatco R, Quelapio M I D, Tupasi T E. Multidrug-resistant tuberculosis among previously treated patients in the Philippines. Int J Tuberc Lung Dis 2011; 15: 652-656.
4. Quelapio M I D, Tupasi T E, Mira N R, Gler M T. The Philippine case study. Bull World Health Organ 2007; 85: 392-393.
5. Kent T K, Kubica G P. Public health mycobacteriology. A guide for the level III laboratory. Atlanta, GA, USA: Centers for Disease Control, 1985: p 168.
6. Orenstein E W, Basu S, Shah N S, et al. Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. Lancet Infect Dis 2009; 9: 153-161.
7. Van Deun A, Maug A K, Salim M A, et al. Short, highly effective, and inexpensive standardised treatment of multidrugr esistant tuberculosis. Am J Respir Crit Care Med 2010; 182: 684-692.
8. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. WHO/HTM/TB/2011.6. Geneva, Switzerland: WHO, 2011.
9. Smith S E, Kurbatova E V, Cavanaugh J S, Cegielski J P. Global isoniazid resistance patterns in rifampin-resistant and rifampin-susceptible tuberculosis. Int J Tuberc Lung Dis 2012; 16: 203-205.
10. Joseph P, Desai V B R, Mohan N S, et al. Outcome of standardized treatment for patients with MDR-TB from Tamil Nadu, India. Indian J Med Res 2011; 133: 529-534.